関西ろうさい病院（兵庫県尼崎市）地域医療支援病院・がん診療連携拠点病院 » がん薬物治療レジメン一覧

- 関西ろうさい病院（兵庫県尼崎市）地域医療支援病院・がん診療連携拠点病院 - https://www.kansaih.johas.go.jp -

がん薬物治療レジメン一覧

2023年4月版

0.MSI-High固形癌

ペムブロリズマブ(MSI-High を有する固形癌)3wks ^[1]

1.脳

5.肺

6.乳腺

乳腺:AC/3wks(注射アロカリス) ^[16]
乳腺:ddAC/2wks(注射アロカリス) ^[17]
乳腺:ddPTX/2wks ^[18]
乳腺:DTX+Per+Tmab B 法/3wks(※Adj) ^[19]
乳腺:DTX+Per+Tmab B 法/3wks(※NAC) ^[20]
乳腺:DTX60/3wks ^[21]
乳腺:DTX75/3wks ^[22]
乳腺:EC/3wks(注射アロカリス) ^[23]
乳腺:GEM 単剤 day1,8/3wks ^[24]
乳腺:Per+Tmab B 法(初回)/3wks ^[25]
乳腺:Per+Tmab B 法(2回目以降)/3wks ^[26]
乳腺:TC/3wks ^[27]
乳腺:Tmab B 法(初回)/3wks ^[28]
乳腺:Tmab B 法(2 回目以降)/3wks ^[29]
乳腺:wPTX+AVA/4wks ^[30]
乳腺:ペムブロリズマブ+AC/3wks(注射アロカリス) ^[31]
乳腺:ペムブロリズマブ+PTX+CBDCA(weekly)/3wks ^[32]

7.食道

8.胃

9.大腸

10.胆肝膵

胆:GEM+CDDP+S-1 /2wks(注射アロカリス) ^[57]
胆:GEM+CDDP(SH)/3wks(注射アロカリス) ^[58]
膵、胆:GEM day1,8,15/4wks ^[59]
膵、胆:GEM+S-1/3wks ^[60]
膵癌:FOLFIRINOX/2wks(注射アロカリス) ^[61]
膵癌:mFOLFIRINOX/2wks(注射アロカリス) ^[62]
膵:Nab-PTX+GEM day1,8,15/4wks ^[63]
膵癌:オニバイド+5-FU+l-LV/2wks(注射アロカリス) ^[64]
胆:Durva+GEM+CDDP(SH)/3wks(注射アロカリス) ^[65]

11.子宮・卵巣

12.泌尿器

13.皮膚

悪性黒色腫:ペムブロリズマブ/3wks ^[77]

URL to article: https://www.kansaih.johas.go.jp/kakuka/section_list/kakuka26/regimen_list.html

URLs in this post:

[1] ペムブロリズマブ(MSI-High を有する固形癌)3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/0_2023_legimen.pdf

[2] 頭頚部:ニボルマブ/2wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/2_2023_legimen.pdf

[3] 非ホジキン:リツキシマブ単剤day1/wk×4回(ソルコーテフ入り): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/3_2023_legimen.pdf

[4] 多発性骨髄腫:ベルケイド点滴day1,4,8,11/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/4_2023_legimen.pdf

[5] NSCLC(再発):BEV/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/5_2023_legimen01.pdf

[6] NSCLC、悪性中皮腫:ニボルマブ/2wks(固定用量): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/5_2023_legimen02.pdf

[7] NSCLC:CBDCA+VNR/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/5_2023_legimen03.pdf

[8] NSCLC:Ipi+Niv+PEM+CBDCA/6wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/5_2023_legimen04.pdf

[9] NSCLC:PEM/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/5_2023_legimen05.pdf

[10] NSCLC:weeklyNab-PTX+CBDCA/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/5_2023_legimen06.pdf

[11] NSCLC:アテゾリズマブ+TC+BEV/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/5_2023_legimen07.pdf

[12] NSCLC:ペムブロリズマブ/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/5_2023_legimen08.pdf

[13] NSCLC:RAM+DTX/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/5_2023_legimen11.pdf

[14] NSCLC:CDDP(SH)+VNR/3wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/5_2023_legimen10.pdf

[15] SCLC:CDDP(SH)+VP-16/4wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/5_2023_legimen09.pdf

[16] 乳腺:AC/3wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen01.pdf

[17] 乳腺:ddAC/2wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen02.pdf

[18] 乳腺:ddPTX/2wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen03.pdf

[19] 乳腺:DTX+Per+Tmab B 法/3wks(※Adj): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen04.pdf

[20] 乳腺:DTX+Per+Tmab B 法/3wks(※NAC): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen05.pdf

[21] 乳腺:DTX60/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen06.pdf

[22] 乳腺:DTX75/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen07.pdf

[23] 乳腺:EC/3wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen08.pdf

[24] 乳腺:GEM 単剤 day1,8/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen09.pdf

[25] 乳腺:Per+Tmab B 法(初回)/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen10.pdf

[26] 乳腺:Per+Tmab B 法(2回目以降)/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen11.pdf

[27] 乳腺:TC/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen12.pdf

[28] 乳腺:Tmab B 法(初回)/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen13.pdf

[29] 乳腺:Tmab B 法(2 回目以降)/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen14.pdf

[30] 乳腺:wPTX+AVA/4wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen15.pdf

[31] 乳腺:ペムブロリズマブ+AC/3wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen16.pdf

[32] 乳腺:ペムブロリズマブ+PTX+CBDCA(weekly)/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/6_2023_legimen17.pdf

[33] 食道:(SH)ペムブロリズマブ+FP(LV2)/3wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/7_2023_legimen01.pdf

[34] 食道:DTX70/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/7_2023_legimen02.pdf

[35] 胃:Nab-PTX100 day1,8,15/4wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/8_2023_legimen01.pdf

[36] 胃:RAM/2wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/8_2023_legimen02.pdf

[37] 胃:RAM+Nab-PTX/4wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/8_2023_legimen03.pdf

[38] 胃:RAM+PTX/4wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/8_2023_legimen04.pdf

[39] 胃:S-1+DTX40/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/8_2023_legimen05.pdf

[40] 胃:SOX/3wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/8_2023_legimen06.pdf

[41] 胃:SOX+T-mab(BS)/3wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/8_2023_legimen07.pdf

[42] 胃:XELOX/3wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/8_2023_legimen08.pdf

[43] 胃:XELOX+T-mab(BS)/3wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/8_2023_legimen09.pdf

[44] 胃:ニボルマブ/2wks(240mg 固定用量): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/8_2023_legimen10.pdf

[45] 胃:ニボルマブ+SOX/3wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/8_2023_legimen11.pdf

[46] 胃:ニボルマブ+XELOX/3wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/8_2023_legimen12.pdf

[47] 大腸:BEV(5mgkg)+IRIS/4wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/9_2023_legimen01.pdf

[48] 大腸:BEV(5mg/kg)+mFOLFOX6/2wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/9_2023_legimen02.pdf

[49] 大腸:BEV+XELOX/3wks(末梢/CV ポート) (注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/9_2023_legimen03.pdf

[50] 大腸:Cmab+CPT-11/2wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/9_2023_legimen04.pdf

[51] 大腸:FOLFOXIRI+BEV/2wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/9_2023_legimen05.pdf

[52] 大腸:mFOLFOX6/2wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/9_2023_legimen06.pdf

[53] 大腸:Pmab+mFOLFOX6/2wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/9_2023_legimen07.pdf

[54] 大腸:RAM+FOLFIRI/2wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/9_2023_legimen08.pdf

[55] 大腸:TAS+BEV/4wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/9_2023_legimen09.pdf

[56] 大腸:XELOX/3wks(末梢/CV ポート): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/9_2023_legimen10.pdf

[57] 胆:GEM+CDDP+S-1 /2wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/06/10_2023_legimen01-2.pdf

[58] 胆:GEM+CDDP(SH)/3wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/10_2023_legimen02.pdf

[59] 膵、胆:GEM day1,8,15/4wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/10_2023_legimen03.pdf

[60] 膵、胆:GEM+S-1/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/10_2023_legimen04.pdf

[61] 膵癌:FOLFIRINOX/2wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/10_2023_legimen05.pdf

[62] 膵癌:mFOLFIRINOX/2wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/10_2023_legimen06.pdf

[63] 膵:Nab-PTX+GEM day1,8,15/4wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/10_2023_legimen07.pdf

[64] 膵癌:オニバイド+5-FU+l-LV/2wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/10_2023_legimen08.pdf

[65] 胆:Durva+GEM+CDDP(SH)/3wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/10_2023_legimen09.pdf

[66] 子宮・卵巣:AP(SH)/3(または4)wks(イメンド併用): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/11_2023_legimen01.pdf

[67] 子宮・卵巣:DP(SH)/3wks(イメンド併用): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/11_2023_legimen02.pdf

[68] 子宮・卵巣:TC(AUC6)/3wks(イメンド併用): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/11_2023_legimen03.pdf

[69] 子宮・卵巣:wTC(AUC6)/3wks(イメンド併用): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/11_2023_legimen04.pdf

[70] 卵巣:Bmab/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/11_2023_legimen05.pdf

[71] 卵巣:Doxl+Carbo+Bmab/4wks(イメンド併用): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/11_2023_legimen06.pdf

[72] 卵巣:wPTX(day1,8,15)+Bmab/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/11_2023_legimen07.pdf

[73] 子宮頸癌:Pembro+TC+Bmab/3wks(注射アロカリス): https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/11_2023_legimen08.pdf

[74] 腎癌:ニボルマブ/2wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/12_2023_legimen01.pdf

[75] 前立腺:DTX75/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/12_2023_legimen02.pdf

[76] 尿路上皮:wGC/4wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/12_2023_legimen03.pdf

[77] 悪性黒色腫:ペムブロリズマブ/3wks: https://www.kansaih.johas.go.jp/wp-content/uploads/2023/05/13_2023_legimen.pdf

Click here to print.